biostudies-literatureUnknown22(12)Franc S<b><i>Background:</i></b> The DIABEO^® system (DS) is a telemedicine solution that combines a mobile app for patients with a web portal for health care providers. DS allows real-time monitoring of basal-bolus insulin therapy as well as therapeutic decision-making, integrating both basal and bolus dose calculation. Real-life studies have shown a very low rate of use of mobile health applications by patients. Therefore, we conducted a large randomized controlled trial study to investigate the efficacy of DS in conditions close to real life (TELESAGE study). <b><i>Methods:</i></b> TELESAGE was a multicenter, randomized, open study with three parallel arms: arm 1 (standard care), arm 2 (DIABEO alone), and arm 3 (DIABEO+telemonitoring by trained nurses). The primary outcome assessed tDiabetes technology & therapeutics904-911https://www.ebi.ac.uk/biostudies/studies/S-EPMC7757616biostudies-literatureDIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen.PMC7757616Simon PCatargi BJeandidier NBorot SPenfornis AFarret AReznik YFontaine Pd'Orsay GSerusclat PDetournay BChaillous LSchaepelynck PGuerci BHanaire HFranc SBenhamou PYKherbachi YCharpentier GfalseDIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen.<b><i>Background:</i></b> The DIABEO^® system (DS) is a telemedicine solution that combines a mobile app for patients with a web portal for health care providers. DS allows real-time monitoring of basal-bolus insulin therapy as well as therapeutic decision-making, integrating both basal and bolus dose calculation. Real-life studies have shown a very low rate of use of mobile health applications by patients. Therefore, we conducted a large randomized controlled trial study to investigate the efficacy of DS in conditions close to real life (TELESAGE study). <b><i>Methods:</i></b> TELESAGE was a multicenter, randomized, open study with three parallel arms: arm 1 (standard care), arm 2 (DIABEO alone), and arm 3 (DIABEO+telemonitoring by trained nurses). The primary outcome assessed t2020-01-01T00:00:00Z2020 Dec2025-04-26T20:10:38.877Z2021-02-20T17:34:55ZS-EPMC77576163240714810.1089/dia.2020.0021